XML 160 R26.htm IDEA: XBRL DOCUMENT v3.24.4
Summary of Significant Accounting Policies (Tables)
 9 Months Ended 12 Months Ended
Sep. 30, 2024
Dec. 31, 2023
Restructuring Cost and Reserve [Line Items]    
Schedule of Accounts Receivable

The following is a summary of the Company’s accounts receivable at September 30, 2024 and December 31, 2023:

  

   September 30, 2024   December 31, 2023 
         
Accounts receivable  $1,636,306   $1,274,112 
Less: allowance for doubtful accounts   81,772    81,772 
Accounts receivable - net  $1,554,534   $1,192,340 

The following is a summary of the Company’s accounts receivable at December 31, 2023 and 2022:

 

  

December 31,

2023

  

December 31,

2022

 
         
Accounts receivable  $1,274,112   $766,692 
Less: allowance for doubtful accounts   81,772    - 
Accounts receivable – net  $1,192,340   $766,692 
Schedule of Concentration of Risk

The Company has the following concentrations related to its sales, accounts receivable and vendor purchases greater than 10% of their respective totals:

  

Sales

 

   Nine Months Ended September 30, 
Customer  2024   2023 
A   20.41%   21.83%
B   10.46%   12.27%
Total   30.87%   34.10%

 

Accounts Receivable

 

   Nine Months Ended September 30,   Year Ended December 31, 2023 
Customer  2024   2023 
A   39.09%   46.57%
B   14.62%   13.50%
Total   53.71%   60.07%

 

Vendor Purchases

 

   Nine Months Ended September 30, 
Vendor  2024   2023 
A   42.86%   50.30%
B   43.39%   37.21%
C   13.62%   11.65%
Total   99.87%   99.16%

The Company has the following concentrations related to its sales, accounts receivable and vendor purchases greater than 10% of their respective totals:

 

Sales

 

   Year Ended December 31, 
Customer  2023   2022 
A   22.19%   11.46%
B   12.07%   11.26%
C   0.00%   31.75%
Total   34.26%   54.47%

 

Accounts Receivable

 

   Year Ended December 31, 
Customer  2023   2022 
A   46.57%   47.48%
B   13.50%   0%
Total   60.07%   47.48%

 

Vendor Purchases

 

   Year Ended December 31, 
Vendor  2023   2022 
A   48.93%   78.62%
B   38.29%   17.91%
C   12.11%   3.15%
Total   99.33%   99.68%
Schedule of Disaggregation of Revenue

The following represents the Company’s disaggregation of revenues for the nine months ended September 30, 2024 and 2023:

  

   Nine Months Ended September 30, 
   2024   2023 
    Revenue     % of Revenues    Revenue     % of Revenues 
                     
Fuel sales  $20,249,067    96.53%  $17,129,808    97.74%
Other   728,793    3.47%   395,869    2.26%
Total Sales  $20,977,860    100.00%  $17,525,677    100.00%

The following represents the Company’s disaggregation of revenues for the years ended December 31, 2023 and 2022:

 

   Years Ended December 31, 
   2023   2022 
   Revenue  

% of

Revenues

   Revenue  

% of

Revenues

 
                 
Fuel sales  $22,677,304    97.68%  $14,860,475    98.78%
Other   539,119    2.32%   184,246    1.22%
Total Sales  $23,216,423    100.00%  $15,044,721    100.00%
Schedule of Dilutive Equity Securities Outstanding

The following potentially dilutive equity securities outstanding as of September 30, 2024 and 2023 were as follows:

 

   September 30, 2024   September 30, 2023 
Series A, preferred stock   1,644,022    - 
Series B, preferred stock    724,638     - 
Series A, preferred stock - dividends   164,402    - 
Series B, preferred stock - dividends   72,464    - 
Warrants (vested)   52,297    81,452 
Total common stock equivalents    2,657,822     81,452 

The following potentially dilutive equity securities outstanding as of December 31, 2023 and 2022 were as follows:

 

  

December 31,

2023

  

December 31,

2022

 
Stock options (vested)   -    11,254 
Warrants (vested)   81,452    81,452 
Total common stock equivalents   81,452    92,706 
Schedule of Unrealized Gains, Losses, and Fair Value  

The following is a summary of the unrealized gains, losses, and fair value by investment type at December 31, 2023 and 2022, respectively:

 

December 31, 2023  Amortized Cost  

Gross Unrealized

Losses

   Fair Value 
                
Corporate Bonds  $-   $-   $- 

 

December 31, 2022  Amortized Cost  

Gross Unrealized

Losses

   Fair Value 
                
Corporate Bonds  $2,164,672   $(44,590)  $2,120,082 
Next NRG Holding Corp [Member]    
Restructuring Cost and Reserve [Line Items]    
Schedule of Fair Value of Assets Acquired and Liabilities

The table below summarizes the estimated fair value of the assets acquired and liabilities assumed:

 

     
Consideration    
     
Cash  $1,800,000 
Note payable   3,700,000 
      
Fair value of consideration transferred  $5,500,000 
      
Recognized amounts of identifiable assets acquired and liabilities assumed:     
      
License agreements  $4,900,000 
Trademarks/Tradenames   600,000 
Total assets acquired   5,500,000 
      
Total liabilities assumed   - 
      
Total identifiable net assets   5,500,000 
      
Goodwill  $- 
  
Schedule of Merketable Securities Related Party Measured at Fair Value

The following table summarizes the Company’s marketable securities – related party measured at fair value on a recurring basis by level within the fair value hierarchy:

 

   Level 1   Level 2   Level 3   Total 
   September 30, 2024 
   Level 1   Level 2   Level 3   Total 
Assets                    
Marketable securities - related party  $12,703,491   $    -   $    -   $12,703,491 
Total Assets  $12,703,491   $-   $-   $12,703,491 

 

   Level 1   Level 2   Level 3   Total 
   December 31, 2023 
   Level 1   Level 2   Level 3   Total 
Assets                    
Marketable securities - related party  $    -   $      -   $    -   $    - 
Total Assets  $-   $-   $-   $- 
  
Schedule of Property Plant and Vehicle Deprication Over Years  

At December 31, 2023, property and equipment consisted of one vehicle (acquired in 2023), which is being depreciated over an estimated useful life of five years as follows:

 

 

      
Vehicle  $88,734 
Less: accumulated depreciation   9,992 
Vehicle – net  $78,742